Friday, April 17, 2020

Zydus Cadila gets USFDA nod to market generic cancer drug

Zydus Cadila gets USFDA nod to market generic cancer drug The company has received final approval from the United States Food and Drug Administration (USFDA) to market Erlotinib tablets in the strengths of 25 mg, 100 mg, and 150 mg, Zydus Cadila said in a statement.

from Moneycontrol Business News https://ift.tt/2wME6Ld
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...